Intermediate Capital Group plc Share Price London S.E.
Equities
GB00BYY5B507
Investment Management & Fund Operators
End-of-day quote
Other stock markets
|
||
- GBX | - |
23/05 | Grey Wolf Therapeutics announced that it has received $99 million in funding from a group of investors | CI |
21/05 | UBS lifts Schroders; Barclays likes Wise | AN |
Sales 2024 * | 886M 1.13B 93.69B | Sales 2025 * | 985M 1.25B 104B | Capitalization | 6.65B 8.46B 703B |
---|---|---|---|---|---|
Net income 2024 * | 402M 512M 42.5B | Net income 2025 * | 443M 564M 46.83B | EV / Sales 2024 * | 8.66 x |
Net Debt 2024 * | 1.03B 1.31B 108B | Net Debt 2025 * | 822M 1.05B 86.92B | EV / Sales 2025 * | 7.58 x |
P/E ratio 2024 * |
16.9
x | P/E ratio 2025 * |
15.3
x | Employees | - |
Yield 2024 * |
3.5% | Yield 2025 * |
3.87% | Free-Float | 97.27% |
Latest transcript on Intermediate Capital Group plc
Managers | Title | Age | Since |
---|---|---|---|
Benoît Durteste
CEO | Chief Executive Officer | 56 | 01/02/01 |
David Bicarregui
DFI | Director of Finance/CFO | 49 | - |
Director/Board Member | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Sykes
BRD | Director/Board Member | 67 | 21/18/21 |
Amy Schioldager
BRD | Director/Board Member | 61 | 25/18/25 |
Director/Board Member | 63 | 01/17/01 |
1st Jan change | Capi. | |
---|---|---|
-3.68% | 116B | |
+7.89% | 98.79B | |
+15.16% | 69.43B | |
+23.96% | 65.73B | |
+13.53% | 44.19B | |
+16.10% | 43.8B | |
+21.85% | 36.26B | |
+9.76% | 26.39B | |
-2.67% | 22.71B |